Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/33D74FFF.svg?ark=w1%2F20260515%2F33D74FFF)](https://nobleid.org/work/w1/20260515/33D74FFF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors